Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 May;40(2):79–97. doi: 10.33176/AACB-18-00017

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

The contents of articles or advertisements in The Clinical Biochemist – Reviews are not to be construed as official statements, evaluations or endorsements by the AACB, its official bodies or its agents. Statements of opinion in AACB publications are those of the contributors. Print Post Approved - PP255003/01665. Copyright © 2005 The Australasian Association of Clinical Biochemists Inc. No literary matter in The Clinical Biochemist – Reviews is to be reproduced, stored in a retrieval system or transmitted in any form by electronic or mechanical means, photocopying or recording, without permission. Requests to do so should be addressed to the Editor. ISSN 0159 – 8090

PMC Copyright notice

Conceptual illustration of precision diagnostics and traditional diagnostics in recognition of kidney injury and disease. Individuals may have genetic susceptibility for kidney injury development during life. Molecular alterations may occur during aging and in response to interventions and these may be recognised by molecular profiling via omics (e.g. metabolomics, peptidomics and proteomics). Precision diagnostics includes the early and precise recognition of genetic susceptibility and molecular alterations. Traditional diagnostics typically recognises late stage kidney damage and decreased kidney function through functional markers, such as serum creatinine, cystatin C and eGFR.